Cargando…

Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR

BACKGROUND: Creatinine-based estimated glomerular filtration rate (eGFR(CRE)) may overestimate kidney function in patients with cancer. Cystatin C-based eGFR (eGFR(CYS)) is an alternative marker of kidney function. We investigated whether patients with an eGFR discrepancy, defined as eGFR(CYS) >3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanna, Paul E., Wang, Qiyu, Strohbehn, Ian, Moreno, Daiana, Harden, Destiny, Ouyang, Tianqi, Katz-Agranov, Nurit, Seethapathy, Harish, Reynolds, Kerry L., Gupta, Shruti, Leaf, David E., Sise, Meghan E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882433/ https://www.ncbi.nlm.nih.gov/pubmed/36711583 http://dx.doi.org/10.1101/2023.01.18.23284656

Ejemplares similares

Medication-Related Adverse Events and Discordancies in Cystatin C–Based vs Serum Creatinine–Based Estimated Glomerular Filtration Rate in Patients With Cancer
por: Hanna, Paul E., et al.
Publicado: (2023)

Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer
por: Hanna, Paul E., et al.
Publicado: (2023)

Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function
por: Seethapathy, Rituvanthikaa, et al.
Publicado: (2023)

Estimated GFR Accuracy When Cystatin C– and Creatinine-Based Estimates Are Discrepant in Older Adults
por: Potok, O. Alison, et al.
Publicado: (2023)

Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012)

Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study
por: Tiu, Bruce C, et al.
Publicado: (2023)

Estimated GFR With Cystatin C and Creatinine in Clinical Practice: A Retrospective Cohort Study
por: Gottlieb, Eric Raphael, et al.
Publicado: (2023)

Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma
por: Wang, Qiyu, et al.
Publicado: (2022)

Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR
por: Wang, Yeli, et al.
Publicado: (2023)

Reduced cystatin C-estimated GFR and increased creatinine-estimated GFR in comparison with iohexol-estimated GFR in a hyperthyroid patient: A case report
por: Karawajczyk, Malgorzata, et al.
Publicado: (2008)

Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma
por: Seethapathy, Harish, et al.
Publicado: (2020)

Performance and Determinants of Serum Creatinine and Cystatin C–Based GFR Estimating Equations in South Asians
por: Wang, Yeli, et al.
Publicado: (2021)

Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza
por: Strohbehn, Ian A., et al.
Publicado: (2021)

Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study
por: Lee, Meghan D, et al.
Publicado: (2021)

Potential relationship between eGFR(cystatin C)/eGFR(creatinine)‐ratio and glomerular basement membrane thickness in diabetic kidney disease
por: Öberg, Carl M., et al.
Publicado: (2021)

Creatinine and cystatin C. There is a lack of studies that compare endogenous and exogenous GFR markers in ICU patients
por: Larsson, Anders
Publicado: (2011)

Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management
por: Seethapathy, Harish, et al.
Publicado: (2021)

Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors
por: Seethapathy, Harish, et al.
Publicado: (2020)

Cystatin C and creatinine-based eGFR levels and their correlation to long-term morbidity and mortality in older adults
por: Werner, Karin, et al.
Publicado: (2018)

eGFR(cystatinC)/eGFR(creatinine) ratio < 0.6 in patients with SARS-CoV-2 pneumonia: a prospective cohort study
por: Avotins, Lauris, et al.
Publicado: (2023)

Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis
por: Sise, Meghan E, et al.
Publicado: (2023)

A Meta-Analysis on the Performance of Cystatin C- versus Creatinine-based eGFR Equations in Predicting Vancomycin Clearance
por: Mohd Tahir, Nor Asyikin, et al.
Publicado: (2020)

Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia
por: Kusunoki, Hiroshi, et al.
Publicado: (2020)

Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease
por: Doğaner, Yusuf Çetin, et al.
Publicado: (2015)

Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check
por: Grubb, Anders
Publicado: (2010)

Factors contributing to discrepant estimated glomerular filtration values measured by creatinine and cystatin C in patients with rheumatoid arthritis
por: Nakashima, Akikatsu, et al.
Publicado: (2021)

Relationships between cystatin C and creatinine‐based eGFR with low tongue pressure in Japanese rural community‐dwelling older adults
por: Kusunoki, Hiroshi, et al.
Publicado: (2022)

Creatinine-based GFR-estimating equations in children with overweight and obesity
por: van Dam, Mark J. C. M., et al.
Publicado: (2022)

Estimating GFR by Serum Creatinine, Cystatin C, and β2-Microglobulin in Older Adults: Results From the Canadian Study of Longevity in Type 1 Diabetes
por: Scarr, Daniel, et al.
Publicado: (2019)

Autoimmunity and COVID-19 – The microbiotal connection
por: Katz-Agranov, Nurit, et al.
Publicado: (2021)

Frequency of Renal Monitoring — Creatinine and Cystatin C (FORM-2C): an observational cohort study of patients with reduced eGFR in primary care
por: Fleming, Susannah, et al.
Publicado: (2021)

GFR Estimation After Cystatin C Reference Material Change
por: Benoit, Stefanie W., et al.
Publicado: (2020)

Severe esophageal injury after radiofrequency ablation - a deadly complication
por: Katz-Agranov, Nurit, et al.
Publicado: (2017)

Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease
por: Beetham, Kassia S., et al.
Publicado: (2018)

Performance of Serum β2-Microglobulin– and β-Trace Protein–Based Panel Markers and 2021 Creatinine- and Cystatin-Based GFR Estimating Equations in Pakistan
por: Wang, Yeli, et al.
Publicado: (2022)

Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m(2) or on Renal Replacement Therapy
por: Estiverne, Christopher, et al.
Publicado: (2020)

Evaluation of cystatin C in malignancy and comparability of estimates of GFR in oncology patients
por: Jones, Melissa, et al.
Publicado: (2017)

Should Cystatin C eGFR Become Routine Clinical Practice?
por: Spencer, Sebastian, et al.
Publicado: (2023)

Positron emission tomography as an adjuvant diagnostic test in the evaluation of checkpoint inhibitor-associated acute interstitial nephritis
por: Qualls, David, et al.
Publicado: (2019)

The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease - prospective longitudinal study in a multiethnic population
por: Lamb, Edmund J, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fm7tara48p433dt64v6p9p4kv9